RecruitingNot ApplicableNCT06275698

HONEY for the Treatment of POst-Tonsillectomy Pain

HONEY for the Treatment of POst-Tonsillectomy Pain - a Double-blind, Randomised, Placebo Controlled, Single Site Trial


Sponsor

East and North Hertfordshire NHS Trust

Enrollment

100 participants

Start Date

Sep 4, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Double-blind, randomised, placebo controlled, single-site trial in adults to compare the effect of Manuka honey with standard of care compared to placebo with standard of care on post-tonsillectomy pain and postoperative outcomes. Main aim is to investigate a potential improvement in post-tonsillectomy pain control, with a low cost and freely available alternative to conventional analgesics. Recent systematic review and multidisciplinary consensus suggest a potential role for the inclusion of honey for this purpose. Clinical efficacy over placebo remains to be conclusively demonstrated in robust clinical trials.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Adult (≥18years old at the time of giving consent)
  • Consented and listed for bilateral tonsillectomy or adenotonsillectomy
  • Tonsillectomy performed within the trial study period

Exclusion Criteria16

  • Any concurrent Head \& Neck (H\&N) malignancy
  • Unilateral tonsillectomy
  • Pregnancy
  • Concurrent pharyngeal or upper aerodigestive tract biopsy
  • Robotic tonsillectomy
  • Previous H\&N malignancy
  • Previous H\&N radiotherapy
  • Type 1/2 diabetes mellitus
  • Known allergy to bee related products
  • Known allergy to golden syrup
  • History of chronic pain
  • History of fibromyalgia
  • Current usage of chronic (>6weeks) analgesia
  • High-risk anaesthetic patients
  • Children or adolescents <18years old
  • Adults unable to consent for themselves

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTManuka honey MGO 1000

Natural Manuka honey, produced in New Zealand. With MGO content ≥ 1000.

DIETARY_SUPPLEMENTSugar-based syrup, thickened with sodium alginate and flavoured with honey flavouring

Sugar-based syrup, thickened with sodium alginate and flavoured with honey flavouring, 15ml, three times a day, for 14 days. To be kept on the tongue for at least 10 seconds prior to swallowing.


Locations(1)

Lister Hospital

Stevenage, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06275698


Related Trials